Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
et al., The Lancet Rheumatology,
Prospective study of 78,674 COVID-19 patients, showing no significant difference in mortality with ibuprofen use.
risk of death, 10.0% lower, OR 0.90, p = 0.36, adjusted per study, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Drake et al., 31 Jul 2021, prospective, United Kingdom, peer-reviewed, 362 authors, study period 17 January, 2020 - 10 August, 2020.